Time-varying voriconazole clearance during extracorporeal membrane oxygenation
Antimicrobial Agents and Chemotherapy · 03.06.2026 · 70 (6)
DOI: 10.1128/aac.00098-26 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 03.06.2026. Verfasst von Hakeem Yusuff und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anaesthesia and Critical Care, Extracorporeal Membrane Oxygenation Unit, University Hospitals of Leicester NHS Trust, Leicester, United…. Hauptthemen laut MEDLINE: Voriconazole, Extracorporeal Membrane Oxygenation, Antifungal Agents, Aspergillosis. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Invasive aspergillosis causes high mortality in critically ill patients, particularly those with viral pneumonitis receiving extracorporeal membrane oxygenation. Achieving effective voriconazole exposure in this setting is difficult, and existing data on drug concentrations during extracorporeal support are inconsistent. To characterize voriconazole pharmacokinetics in adults receiving extracorporeal membrane oxygenation and evaluate the influence of CYP2C19 genotype on drug exposure. This single-center prospective observational study included adults treated with intravenous voriconazole for suspected or confirmed aspergillosis during extracorporeal support. Serial plasma samples were analyzed using population pharmacokinetic modeling to describe drug disposition and simulate dosing regimens. Thirty-one patients (median age 40 years, mean weight 87 kilograms) provided 131 plasma samples; 61% carried reduced-function CYP2C19 variants. Voriconazole concentrations varied widely, with subtherapeutic levels increasing from 28% on days 1–5 to 47% by days 6–10. A dual-pathway model incorporating an early, rapidly decaying circuit sequestration process followed by a logistic rise in intrinsic clearance from 6.2 to 22.3 liters per h best described the data. Intermediate or poor metabolizers had 36% lower late-phase clearance, though genotype effects were estimated with substantial uncertainty. Simulations indicated that standard dosing achieved therapeutic concentrations in only half of patients at 48 h, declining sharply by day 7. Voriconazole clearance during extracorporeal membrane oxygenation is time-varying, with evidence of early circuit sequestration and later metabolic recovery influenced by CYP2C19 genotype. Early and repeated monitoring is required to maintain effective antifungal exposure. Time-varying clearance should inform dosing of voriconazole and other hepatically metabolized agents during extracorporeal support. CLINICAL TRIALS This study is registered with ClinicalTrials.gov as NCT04868188 .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anaesthesia and Critical Care, Extracorporeal Membrane Oxygenation Unit, University Hospitals of Leicester NHS Trust, Leicester, United Kingdom.
- Department of Respiratory Sciences, University of Leicester, Leicester, United Kingdom.
- National Institute of Heath Research (NIHR) Leicester Biomedical Research Centre, Glenfield Hospital, Leicester, United Kingdom.
- Department of Pharmacy, Glenfield Hospital, University Hospitals of Leicester NHS Trust, Leicester, United Kingdom.
- Department of Cardiovascular Sciences, University of Leicester, Leicester, United Kingdom.
- Department of Microbiology, University Hospitals of Leicester NHS Trust, Leicester, United Kingdom.
ORCID-Profile: Hakeem Yusuff, Vasileios Zochios
Zitieren
APA
Yusuff, H., Gadsby, J., Isgro, G., Zochios, V., Jenkins, D., Cooke, S., & Mulla, H. (2026). Time-varying voriconazole clearance during extracorporeal membrane oxygenation. Antimicrobial Agents and Chemotherapy, 70(6). https://doi.org/10.1128/aac.00098-26
Vancouver
Yusuff H, Gadsby J, Isgro G, Zochios V, Jenkins D, Cooke S, et al. Time-varying voriconazole clearance during extracorporeal membrane oxygenation. Antimicrobial Agents and Chemotherapy. 2026;70(6). doi:10.1128/aac.00098-26
BibTeX
@article{Yusuff2026,
author = {Yusuff, Hakeem and Gadsby, Jessica and Isgro, Graziella and Zochios, Vasileios and Jenkins, David and Cooke, Sarah and Mulla, Hussain},
title = {Time-varying voriconazole clearance during extracorporeal membrane oxygenation},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2026},
volume = {70},
number = {6},
doi = {10.1128/aac.00098-26}
}
EUVIMED